U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Bernard A. Harris, Jr. sold 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total value of $185,900.00. Following the sale, the director now owns 16,726 shares in the company, valued at $1,554,681.70. This represents a 10.68 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
U.S. Physical Therapy Stock Down 1.8 %
USPH stock opened at $90.18 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.88. U.S. Physical Therapy, Inc. has a 1-year low of $76.18 and a 1-year high of $113.63. The stock has a market capitalization of $1.36 billion, a P/E ratio of 95.94, a P/E/G ratio of 4.15 and a beta of 1.38. The business has a fifty day moving average price of $84.09 and a 200-day moving average price of $91.25.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. During the same period in the previous year, the firm earned $0.76 EPS. The business’s revenue was up 10.4% on a year-over-year basis. Equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
Analysts Set New Price Targets
A number of research analysts have issued reports on USPH shares. Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 7th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Finally, Bank of America reiterated a “neutral” rating and set a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th.
Get Our Latest Stock Analysis on USPH
Hedge Funds Weigh In On U.S. Physical Therapy
A number of hedge funds have recently made changes to their positions in the business. Rockefeller Capital Management L.P. boosted its stake in shares of U.S. Physical Therapy by 18.8% in the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock worth $13,578,000 after acquiring an additional 25,393 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock worth $223,000 after buying an additional 956 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of U.S. Physical Therapy by 283.0% in the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after buying an additional 12,445 shares in the last quarter. Quantbot Technologies LP lifted its position in shares of U.S. Physical Therapy by 57.6% in the third quarter. Quantbot Technologies LP now owns 10,876 shares of the company’s stock worth $920,000 after buying an additional 3,973 shares in the last quarter. Finally, Intech Investment Management LLC purchased a new stake in shares of U.S. Physical Therapy in the third quarter worth about $356,000.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles
- Five stocks we like better than U.S. Physical Therapy
- How to Buy Cheap Stocks Step by Step
- 3 Stocks Near 52-Week Lows That Could Be Top Buys Right Now
- Best Stocks Under $10.00
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What Are Growth Stocks and Investing in Them
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.